Kraft Heinz Reports Second Quarter 2024 Results
Lowers Full Year Outlook for Organic
Reaffirms Full Year Outlook for Adjusted EPS(1)(2)
Second Quarter Highlights
-
Net sales decreased 3.6%; Organic
Net Sales (1) decreased 2.4%
-
Gross profit margin increased 180 basis points to 35.4%; Adjusted Gross Profit Margin(1) increased 210 basis points to 35.5%
-
Operating income decreased 62.1%; Adjusted Operating Income(1) increased 2.0%
-
Diluted EPS was
$0.08 , down 90.1%; Adjusted EPS(1) was$0.78 , down 1.3%
-
Year-to-date net cash provided by operating activities was
$1.7 billion , up 8.1%; Free Cash Flow(1) was$1.2 billion , up 8.7%
-
Year-to-date return of capital to stockholders was
$1.5 billion
“Our second quarter net sales growth came in lower than originally anticipated, as consumer sentiment remains cautious,” said
“As we enter the second half of 2024, many drivers are giving us optimism for improved top-line trends. We are anticipating a continued ramp up of both innovation and renovation, particularly in North America Retail, and we are increasing our marketing investment to continue to drive brand superiority across our portfolio. In Away From Home and Emerging Markets, we expect to increase distribution through our go-to-market strategy and global activations. Finally, understanding that the consumer is looking for value, we will selectively increase investments in promotions.”
Abrams-Rivera continued, “We remain confident in our strategy and in the attractive categories in which we compete. We are committed to managing our business in a disciplined manner that preserves our ability to drive sustainable, long-term growth.”
|
|
|
|
|
|
|
|
|
|
|
|
|
||
In millions |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
Organic |
||||||||||
|
|
|
|
|
|
% Chg vs PY |
|
YoY Growth
|
|
Price |
|
Volume/
|
||
For the Three Months Ended |
|
|
|
|
|
|
|
|
|
|||||
|
|
$ |
4,921 |
|
$ |
5,079 |
|
(3.1)% |
|
(2.9)% |
|
1.3 pp |
|
(4.2) pp |
International Developed Markets |
|
|
885 |
|
|
932 |
|
(5.0)% |
|
(3.9)% |
|
(1.5) pp |
|
(2.4) pp |
Emerging Markets(a) |
|
|
670 |
|
|
710 |
|
(5.7)% |
|
3.4% |
|
1.9 pp |
|
1.5 pp |
|
|
$ |
6,476 |
|
$ |
6,721 |
|
(3.6)% |
|
(2.4)% |
|
1.0 pp |
|
(3.4) pp |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
In millions |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
Organic |
||||||||||
|
|
|
|
|
|
% Chg vs PY |
|
YoY Growth
|
|
Price |
|
Volume/
|
||
For the Six Months Ended |
|
|
|
|
|
|
|
|
|
|||||
|
|
$ |
9,749 |
|
$ |
9,964 |
|
(2.2)% |
|
(2.1)% |
|
1.9 pp |
|
(4.0) pp |
International Developed Markets |
|
|
1,740 |
|
|
1,792 |
|
(2.9)% |
|
(2.6)% |
|
0.5 pp |
|
(3.1) pp |
Emerging Markets(a) |
|
|
1,398 |
|
|
1,454 |
|
(3.8)% |
|
4.4% |
|
2.9 pp |
|
1.5 pp |
|
|
$ |
12,887 |
|
$ |
13,210 |
|
(2.4)% |
|
(1.5)% |
|
1.8 pp |
|
(3.3) pp |
(a) |
Emerging Markets represents the aggregation of our West and East Emerging Markets (“WEEM”) and Asia Emerging Markets (“AEM”) operating segments. |
Net Income/(Loss) and Diluted EPS |
|
|
|
|
||||||||||||
In millions, except per share data |
|
|
|
|
|
|
|
|
|
|
||||||
|
|
For the Three Months Ended |
|
For the Six Months Ended |
||||||||||||
|
|
|
|
|
|
% Chg vs PY |
|
|
|
|
|
% Chg vs PY |
||||
Gross profit |
|
$ |
2,294 |
|
$ |
2,261 |
|
1.5% |
|
$ |
4,537 |
|
$ |
4,374 |
|
3.7% |
Operating income/(loss) |
|
|
522 |
|
|
1,376 |
|
(62.1)% |
|
|
1,824 |
|
|
2,619 |
|
(30.4)% |
Net income/(loss) |
|
|
100 |
|
|
998 |
|
(90.0)% |
|
|
904 |
|
|
1,835 |
|
(50.7)% |
Net income/(loss) attributable to common shareholders |
|
|
102 |
|
|
1,000 |
|
(89.8)% |
|
|
903 |
|
|
1,836 |
|
(50.8)% |
Diluted EPS |
|
$ |
0.08 |
|
$ |
0.81 |
|
(90.1)% |
|
$ |
0.74 |
|
$ |
1.49 |
|
(50.3)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted EPS(1) |
|
|
0.78 |
|
|
0.79 |
|
(1.3)% |
|
|
1.47 |
|
|
1.48 |
|
(0.7)% |
Adjusted Operating Income(1) |
|
$ |
1,380 |
|
$ |
1,351 |
|
2.0% |
|
$ |
2,645 |
|
$ |
2,596 |
|
1.9% |
Q2 2024 Financial Summary
-
Net sales decreased 3.6 percent versus the year-ago period to
$6.5 billion , including a negative 1.0 percentage point impact from foreign currency and a negative 0.2 percentage point impact from divestitures. OrganicNet Sales (1) decreased 2.4 percent versus the prior year period. Price increased 1.0 percentage points versus the prior year period, with increases in theNorth America and Emerging Markets segments partially offset by lower price in International Developed Markets. Favorable price was primarily due to pricing taken in certain categories to mitigate higher input costs. Volume/mix declined 3.4 percentage points versus the prior year period, with declines in theNorth America and International Developed Markets segments partially offset by volume/mix growth in Emerging Markets. Unfavorable volume/mix was primarily due to waning consumer sentiment. -
Operating Income decreased 62.1 percent versus the year-ago period to
$0.5 billion , primarily driven by non-cash impairment losses of$854 million in the current year period. Adjusted Operating Income(1) increased 2.0 percent versus the year-ago period to$1.4 billion , primarily driven by gross savings, including lower commodity and logistics costs, and higher pricing. This more than offset unfavorable volume/mix, increased selling, general and administrative expenses primarily driven by investments in marketing and technology, and an unfavorable impact from foreign currency (0.7 pp). -
Diluted EPS was
$0.08 , down 90.1 percent versus the prior year period, primarily driven by non-cash impairment losses in the current year period. Adjusted EPS(1) was$0.78 , down 1.3 percent versus the prior year period, primarily driven by lapping a one-time tax benefit in the prior year associated with a net decrease in uncertain tax position reserves. The lapping of this one-time tax benefit more than offset higher Adjusted Operating Income, fewer shares outstanding, and favorable changes in other expense/(income). -
Year-to-date net cash provided by/(used for) operating activities was
$1.7 billion , up 8.1 percent versus the year-ago period. This increase was primarily due to favorable improvements in working capital, predominantly within inventory and accounts payable, as well as higher Adjusted Operating Income. These impacts were partially offset by higher cash outflows for variable compensation in the 2024 period compared to the 2023 period. Free Cash Flow(1) was$1.2 billion , up 8.7 percent versus the prior year period, driven by the same net cash provided by/(used for) operating activities discussed above. These factors more than offset an increase of$35 million in capital expenditures in the current year. -
Capital Return: Year to date, the Company paid
$969 million in cash dividends and repurchased$537 million of common stock. Of the$537 million in share repurchases in 2024,$350 million were repurchased under the Company’s publicly announced share repurchase program and$187 million were purchased to offset the dilutive effect of equity-based compensation. As ofJune 29, 2024 , the Company had remaining authorization to repurchase$2.4 billion of common stock under the publicly announced share repurchase program.
Outlook
For fiscal year 2024, the Company now expects:
-
Organic
Net Sales (2) to be down 2 percent to flat versus the prior year, compared to the previous expectation of 0 to 2 percent growth.
-
Adjusted Operating Income(2) growth of 1 to 3 percent versus the prior year, compared to the previous expectation of 2 to 4 percent growth. This contemplates expected Adjusted Gross Profit Margin(1)(2) expansion in the range of 75 to 125 basis points versus the prior year, compared to the previous expectation of 50 to 100 basis points versus the prior year.
-
Adjusted EPS(2) growth of 1 to 3 percent, or in the range of
$3.01 to$3.07 , which is the same as prior expectations. The Company continues to expect an effective tax rate on Adjusted EPS to be in the range of 20 to 22 percent. Additionally, the Company expects an unfavorable impact of approximately$30 million within interest expense and other expense/(income) versus the prior year. The outlook does not contemplate any potential additional share repurchases in 2024.
End Notes
(1) |
Organic |
(2) |
Guidance for Organic |
Earnings Discussion and Webcast Information
A pre-recorded management discussion of
ABOUT
We are driving transformation at
Forward-Looking Statements
This press release contains a number of forward-looking statements. Words such as “accelerate,” “anticipate,” “believe,” “commit,” “continue,” “expect,” “will,” “guidance,” and “outlook,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding the Company's plans, impacts of accounting standards and guidance, growth, legal matters, taxes, costs and cost savings, impairments, dividends, expectations, investments, innovations, opportunities, capabilities, execution, initiatives, and pipeline. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond the Company's control.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, operating in a highly competitive industry; the Company’s ability to correctly predict, identify, and interpret changes in consumer preferences and demand, to offer new products to meet those changes, and to respond to competitive innovation; changes in the retail landscape or the loss of key retail customers; changes in the Company's relationships with significant customers or suppliers, or in other business relationships; the Company’s ability to maintain, extend, and expand its reputation and brand image; the Company’s ability to leverage its brand value to compete against private label products; the Company’s ability to drive revenue growth in its key product categories or platforms, increase its market share, or add products that are in faster-growing and more profitable categories; product recalls or other product liability claims; climate change and legal or regulatory responses; the Company’s ability to identify, complete, or realize the benefits from strategic acquisitions, divestitures, alliances, joint ventures, or investments; the Company's ability to successfully execute its strategic initiatives; the impacts of the Company's international operations; the Company's ability to protect intellectual property rights; the Company’s ability to realize the anticipated benefits from prior or future streamlining actions to reduce fixed costs, simplify or improve processes, and improve its competitiveness; the influence of the Company's largest stockholder; the Company's level of indebtedness, as well as our ability to comply with covenants under our debt instruments; additional impairments of the carrying amounts of goodwill or other indefinite-lived intangible assets; foreign exchange rate fluctuations; volatility in commodity, energy, and other input costs; volatility in the market value of all or a portion of the commodity derivatives we use; compliance with laws and regulations and related legal claims or regulatory enforcement actions; failure to maintain an effective system of internal controls; a downgrade in the Company's credit rating; the impact of sales of the Company's common stock in the public market; the impact of the Company’s share repurchases or any change in the Company’s share repurchase activity; the Company’s ability to continue to pay a regular dividend and the amounts of any such dividends; disruptions in the global economy caused by geopolitical conflicts, unanticipated business disruptions and natural events in the locations in which the Company or the Company's customers, suppliers, distributors, or regulators operate; economic and political conditions in
We use our investor relations website, ir.kraftheinzcompany.com, as a routine channel for distribution of important, and often material, information about
Non-GAAP Financial Measures
The non-GAAP financial measures provided in this press release should be viewed in addition to, and not as an alternative for, results prepared in accordance with accounting principles generally accepted in
To supplement the financial information provided, the Company has presented Organic
Management uses these non-GAAP financial measures to assist in comparing the Company’s performance on a consistent basis for purposes of business decision making by removing the impact of certain items that management believes do not directly reflect the Company’s underlying operations. The Company believes:
-
Organic
Net Sales , Adjusted Operating Income, Constant Currency Adjusted Operating Income, Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted Net Income/(Loss), and Adjusted EPS provide important comparability of underlying operating results, allowing investors and management to assess the Company’s operating performance on a consistent basis; and
- Free Cash Flow and Net Leverage provide measures of the Company’s core operating performance, the cash-generating capabilities of the Company’s business operations, and are factors used in determining the Company’s borrowing capacity and the amount of cash available for debt repayments, dividends, acquisitions, share repurchases, and other corporate purposes.
Management believes that presenting the Company’s non-GAAP financial measures is useful to investors because it (i) provides investors with meaningful supplemental information regarding financial performance by excluding certain items, (ii) permits investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating the Company’s results. The Company believes that the presentation of these non-GAAP financial measures, when considered together with the corresponding GAAP financial measures and the reconciliations to those measures, provides investors with additional understanding of the factors and trends affecting the Company’s business than could be obtained absent these disclosures.
Definitions
Organic
Adjusted Operating Income is defined as operating income/(loss) excluding, when they occur, the impacts of restructuring activities, deal costs, unrealized gains/(losses) on commodity hedges (the unrealized gains and losses are recorded in general corporate expenses until realized; once realized, the gains and losses are recorded in the applicable segment’s operating results), impairment losses, and certain non-ordinary course legal and regulatory matters. The Company also presents Adjusted Operating Income on a constant currency basis (Constant Currency Adjusted Operating Income). The Company calculates the impact of currency on Adjusted Operating Income by holding exchange rates constant at the previous year's exchange rate, with the exception of highly inflationary subsidiaries, for which it calculates the previous year's results using the current year's exchange rate.
Adjusted Gross Profit, Adjusted Net Income/(Loss), and Adjusted EPS are defined as gross profit, net income/(loss), and diluted earnings per share, respectively, excluding, when they occur, the impacts of restructuring activities, deal costs, unrealized losses/(gains) on commodity hedges, impairment losses, certain non-ordinary course legal and regulatory matters, losses/(gains) on the sale of a business, other losses/(gains) related to acquisitions and divestitures (e.g., tax and hedging impacts), nonmonetary currency devaluation (e.g., remeasurement gains and losses), debt prepayment and extinguishment (benefit)/costs, and certain significant discrete income tax items (e.g.,
Net Leverage is defined as debt less cash, cash equivalents and short-term investments divided by Adjusted EBITDA. Adjusted EBITDA is defined as net income/(loss) from continuing operations before interest expense, other expense/(income), provision for/(benefit from) income taxes, and depreciation and amortization (excluding restructuring activities); in addition to these adjustments, the Company excludes, when they occur, the impacts of divestiture-related license income, restructuring activities, deal costs, unrealized losses/(gains) on commodity hedges, impairment losses, certain non-ordinary course legal and regulatory matters, and equity award compensation expense (excluding restructuring activities).
Free Cash Flow is defined as net cash provided by/(used for) operating activities less capital expenditures. The use of this non-GAAP measure does not imply or represent the residual cash flow for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure.
|
|
|
|
||||||||
|
|
|
|
|
|
|
Schedule 1 |
||||
Condensed Consolidated Statements of Income (in millions, except per share data) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Net sales |
$ |
6,476 |
|
$ |
6,721 |
|
$ |
12,887 |
|
$ |
13,210 |
Cost of products sold |
|
4,182 |
|
|
4,460 |
|
|
8,350 |
|
|
8,836 |
Gross profit |
|
2,294 |
|
|
2,261 |
|
|
4,537 |
|
|
4,374 |
Selling, general and administrative expenses, excluding impairment losses |
|
918 |
|
|
885 |
|
|
1,859 |
|
|
1,755 |
|
|
854 |
|
|
— |
|
|
854 |
|
|
— |
Selling, general and administrative expenses |
|
1,772 |
|
|
885 |
|
|
2,713 |
|
|
1,755 |
Operating income/(loss) |
|
522 |
|
|
1,376 |
|
|
1,824 |
|
|
2,619 |
Interest expense |
|
229 |
|
|
228 |
|
|
455 |
|
|
455 |
Other expense/(income) |
|
(55) |
|
|
(24) |
|
|
(8) |
|
|
(59) |
Income/(loss) before income taxes |
|
348 |
|
|
1,172 |
|
|
1,377 |
|
|
2,223 |
Provision for/(benefit from) income taxes |
|
248 |
|
|
174 |
|
|
473 |
|
|
388 |
Net income/(loss) |
|
100 |
|
|
998 |
|
|
904 |
|
|
1,835 |
Net income/(loss) attributable to noncontrolling interest |
|
(2) |
|
|
(2) |
|
|
1 |
|
|
(1) |
Net income/(loss) attributable to common shareholders |
$ |
102 |
|
$ |
1,000 |
|
$ |
903 |
|
$ |
1,836 |
|
|
|
|
|
|
|
|
||||
Basic shares outstanding |
|
1,212 |
|
|
1,228 |
|
|
1,213 |
|
|
1,227 |
Diluted shares outstanding |
|
1,216 |
|
|
1,235 |
|
|
1,219 |
|
|
1,235 |
|
|
|
|
|
|
|
|
||||
Per share data applicable to common shareholders: |
|
|
|
|
|
|
|
||||
Basic earnings/(loss) per share |
$ |
0.08 |
|
$ |
0.81 |
|
$ |
0.74 |
|
$ |
1.50 |
Diluted earnings/(loss) per share |
|
0.08 |
|
|
0.81 |
|
|
0.74 |
|
|
1.49 |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
Schedule 2 |
||||||
Reconciliation of For the Three Months Ended (dollars in millions) (Unaudited) |
|||||||||||||||
|
|
|
Currency |
|
Acquisitions and Divestitures |
|
Organic |
|
Price |
|
Volume/Mix |
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
4,921 |
|
$ |
(9) |
|
$ |
— |
|
$ |
4,930 |
|
|
|
|
International Developed Markets |
|
885 |
|
|
(11) |
|
|
— |
|
|
896 |
|
|
|
|
Emerging Markets |
|
670 |
|
|
(30) |
|
|
2 |
|
|
698 |
|
|
|
|
|
$ |
6,476 |
|
$ |
(50) |
|
$ |
2 |
|
$ |
6,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
5,079 |
|
$ |
— |
|
$ |
— |
|
$ |
5,079 |
|
|
|
|
International Developed Markets |
|
932 |
|
|
— |
|
|
— |
|
|
932 |
|
|
|
|
Emerging Markets |
|
710 |
|
|
19 |
|
|
16 |
|
|
675 |
|
|
|
|
|
$ |
6,721 |
|
$ |
19 |
|
$ |
16 |
|
$ |
6,686 |
|
|
|
|
Year-over-year growth rates |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
(3.1)% |
|
(0.2) pp |
|
0.0 pp |
|
|
(2.9)% |
|
1.3 pp |
|
(4.2) pp |
||
International Developed Markets |
|
(5.0)% |
|
(1.1) pp |
|
0.0 pp |
|
|
(3.9)% |
|
(1.5) pp |
|
(2.4) pp |
||
Emerging Markets |
|
(5.7)% |
|
(7.0) pp |
|
(2.1) pp |
|
|
3.4% |
|
1.9 pp |
|
1.5 pp |
||
|
|
(3.6)% |
|
(1.0) pp |
|
(0.2) pp |
|
|
(2.4)% |
|
1.0 pp |
|
(3.4) pp |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
Schedule 3 |
||||||
Reconciliation of For the Six Months Ended (dollars in millions) (Unaudited) |
|||||||||||||||
|
|
|
Currency |
|
Acquisitions and Divestitures |
|
Organic |
|
Price |
|
Volume/Mix |
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
9,749 |
|
$ |
(7) |
|
$ |
— |
|
$ |
9,756 |
|
|
|
|
International Developed Markets |
|
1,740 |
|
|
(5) |
|
|
— |
|
|
1,745 |
|
|
|
|
Emerging Markets(a) |
$ |
1,398 |
|
$ |
(46) |
|
$ |
12 |
|
$ |
1,432 |
|
|
|
|
|
$ |
12,887 |
|
$ |
(58) |
|
$ |
12 |
|
$ |
12,933 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
9,964 |
|
$ |
— |
|
$ |
— |
|
$ |
9,964 |
|
|
|
|
International Developed Markets |
|
1,792 |
|
|
— |
|
|
— |
|
|
1,792 |
|
|
|
|
Emerging Markets(a) |
$ |
1,454 |
|
$ |
49 |
|
$ |
34 |
|
$ |
1,371 |
|
|
|
|
|
$ |
13,210 |
|
$ |
49 |
|
$ |
34 |
|
$ |
13,127 |
|
|
|
|
Year-over-year growth rates |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
(2.2)% |
|
(0.1) pp |
|
0.0 pp |
|
|
(2.1)% |
|
1.9 pp |
|
(4.0) pp |
||
International Developed Markets |
|
(2.9)% |
|
(0.3) pp |
|
0.0 pp |
|
|
(2.6)% |
|
0.5 pp |
|
(3.1) pp |
||
Emerging Markets(a) |
|
(3.8)% |
|
(6.6) pp |
|
(1.6) pp |
|
|
4.4% |
|
2.9 pp |
|
1.5 pp |
||
|
|
(2.4)% |
|
(0.8) pp |
|
(0.1) pp |
|
|
(1.5)% |
|
1.8 pp |
|
(3.3) pp |
(a) |
Emerging Markets represents the aggregation of our WEEM and AEM operating segments. |
|
|
|
|
||||||||
|
|
|
|
|
Schedule 4 |
||||||
Reconciliation of Operating Income/(Loss) to Adjusted Operating Income (dollars in millions) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Operating income/(loss) |
$ |
522 |
|
$ |
1,376 |
|
|
1,824 |
|
|
2,619 |
Restructuring activities |
|
3 |
|
|
(10) |
|
|
— |
|
|
(20) |
Unrealized losses/(gains) on commodity hedges |
|
1 |
|
|
(16) |
|
|
(33) |
|
|
(5) |
Impairment losses |
|
854 |
|
|
— |
|
|
854 |
|
|
— |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
1 |
|
|
— |
|
|
2 |
Adjusted Operating Income |
$ |
1,380 |
|
$ |
1,351 |
|
$ |
2,645 |
|
$ |
2,596 |
|
|
|
|
|
|
|
|
||||
Segment Adjusted Operating Income: |
|
|
|
|
|
|
|
||||
|
$ |
1,341 |
|
$ |
1,247 |
|
$ |
2,556 |
|
$ |
2,456 |
International Developed Markets |
|
126 |
|
|
140 |
|
|
262 |
|
|
247 |
Total Segment Adjusted Operating Income |
|
1,467 |
|
|
1,387 |
|
|
2,818 |
|
|
2,703 |
Emerging Markets Segment Adjusted Operating Income(a) |
|
66 |
|
|
97 |
|
|
148 |
|
|
198 |
General corporate expenses |
|
(153) |
|
|
(133) |
|
|
(321) |
|
|
(305) |
Adjusted Operating Income |
$ |
1,380 |
|
$ |
1,351 |
|
$ |
2,645 |
|
$ |
2,596 |
(a) |
Segment Adjusted Operating Income for Emerging Markets, which represents the combination of our WEEM and AEM operating segments, is defined and presented consistently with the Segment Adjusted Operating Income of our reportable segments - |
|
|
|
|
|||||
|
|
|
|
|
Schedule 5 |
|||
Reconciliation of Adjusted Operating Income to Constant Currency Adjusted Operating Income For the Three Months Ended (dollars in millions) (Unaudited) |
||||||||
|
Adjusted Operating Income |
|
Currency |
|
Constant Currency Adjusted Operating Income |
|||
|
|
|
|
|
|
|||
|
$ |
1,341 |
|
$ |
(2) |
|
$ |
1,343 |
International Developed Markets |
|
126 |
|
|
— |
|
|
126 |
Emerging Markets |
|
66 |
|
|
(3) |
|
|
69 |
General corporate expenses |
|
(153) |
|
|
— |
|
|
(153) |
|
$ |
1,380 |
|
$ |
(5) |
|
$ |
1,385 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
$ |
1,247 |
|
$ |
— |
|
$ |
1,247 |
International Developed Markets |
|
140 |
|
|
— |
|
|
140 |
Emerging Markets |
|
97 |
|
|
3 |
|
|
94 |
General corporate expenses |
|
(133) |
|
|
— |
|
|
(133) |
|
$ |
1,351 |
|
$ |
3 |
|
$ |
1,348 |
Year-over-year growth rates |
|
|
|
|
|
|||
|
|
7.5% |
|
(0.2) pp |
|
|
7.7% |
|
International Developed Markets |
|
(10.0)% |
|
(0.2) pp |
|
|
(9.8)% |
|
Emerging Markets |
|
(32.7)% |
|
(6.6) pp |
|
|
(26.1)% |
|
General corporate expenses |
|
15.3% |
|
(0.4) pp |
|
|
15.7% |
|
|
|
2.0% |
|
(0.7) pp |
|
|
2.7% |
|
|
|
||||||
|
|
|
Schedule 6 |
|||||
Reconciliation of Adjusted Operating Income to Constant Currency Adjusted Operating Income For the Six Months Ended (dollars in millions) (Unaudited) |
||||||||
|
Adjusted Operating Income |
Currency |
Constant Currency Adjusted Operating Income |
|||||
|
|
|
||||||
|
$ |
2,556 |
$ |
(1) |
$ |
2,557 |
||
International Developed Markets |
|
262 |
|
4 |
|
258 |
||
Emerging Markets |
|
148 |
|
(7) |
|
155 |
||
General corporate expenses |
|
(321) |
|
(1) |
|
(320) |
||
|
$ |
2,645 |
$ |
(5) |
$ |
2,650 |
||
|
|
|
||||||
|
|
|
||||||
|
$ |
2,456 |
$ |
— |
$ |
2,456 |
||
International Developed Markets |
|
247 |
|
— |
|
247 |
||
Emerging Markets |
|
198 |
|
9 |
|
189 |
||
General corporate expenses |
|
(305) |
|
— |
|
(305) |
||
|
$ |
2,596 |
$ |
9 |
$ |
2,587 |
||
Year-over-year growth rates |
|
|||||||
|
|
4.0% |
(0.1) pp |
|
4.1% |
|||
International |
|
6.4% |
1.6 pp |
|
4.8% |
|||
Emerging Markets |
|
(25.4)% |
(7.7) pp |
|
(17.7)% |
|||
General corporate expenses |
|
5.1% |
0.2 pp |
|
4.9% |
|||
|
|
1.9% |
(0.6) pp |
|
2.5% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 7 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Three Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross profit |
|
Selling, general and administrative expenses |
|
Operating income/(loss) |
|
Interest expense |
|
Other expense/(income) |
|
Income/(loss) before income taxes |
|
Provision for/(benefit from) income taxes |
|
Net income/(loss) |
|
Net income/(loss) attributable to noncontrolling interest |
|
Net income/(loss) attributable to common shareholders |
|
Diluted EPS |
|||||||||||
GAAP Results |
$ |
2,294 |
|
$ |
1,772 |
|
$ |
522 |
|
$ |
229 |
|
$ |
(55) |
|
$ |
348 |
|
$ |
248 |
|
$ |
100 |
|
$ |
(2) |
|
$ |
102 |
|
$ |
0.08 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
1 |
|
|
(2) |
|
|
3 |
|
|
— |
|
|
1 |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
1 |
|
|
— |
|
|
1 |
|
|
— |
|
|
— |
|
|
1 |
|
|
1 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
Impairment losses |
|
— |
|
|
(854) |
|
|
854 |
|
|
— |
|
|
— |
|
|
854 |
|
|
— |
|
|
854 |
|
|
— |
|
|
854 |
|
|
0.70 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
1 |
|
|
(1) |
|
|
13 |
|
|
(14) |
|
|
— |
|
|
(14) |
|
|
— |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
Adjusted Non-GAAP Results |
$ |
2,296 |
|
|
|
$ |
1,380 |
|
|
|
|
|
|
|
|
|
$ |
943 |
|
|
|
|
|
$ |
0.78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 8 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Three Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross profit |
|
Selling, general and administrative expenses |
|
Operating income/(loss) |
|
Interest expense |
|
Other expense/(income) |
|
Income/(loss) before income taxes |
|
Provision for/(benefit from) income taxes |
|
Net income/(loss) |
|
Net income/(loss) attributable to noncontrolling interest |
|
Net income/(loss) attributable to common shareholders |
|
Diluted EPS |
|||||||||||
GAAP Results |
$ |
2,261 |
|
$ |
885 |
|
$ |
1,376 |
|
$ |
228 |
|
$ |
(24) |
|
$ |
1,172 |
|
$ |
174 |
|
$ |
998 |
|
$ |
(2) |
|
$ |
1,000 |
|
$ |
0.81 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
(6) |
|
|
4 |
|
|
(10) |
|
|
— |
|
|
— |
|
|
(10) |
|
|
(2) |
|
|
(8) |
|
|
— |
|
|
(8) |
|
|
(0.01) |
Unrealized losses/(gains) on commodity hedges |
|
(16) |
|
|
— |
|
|
(16) |
|
|
— |
|
|
— |
|
|
(16) |
|
|
(3) |
|
|
(13) |
|
|
— |
|
|
(13) |
|
|
(0.01) |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
— |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(15) |
|
|
15 |
|
|
— |
|
|
15 |
|
|
— |
|
|
15 |
|
|
0.01 |
Certain significant discrete income tax items |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
17 |
|
|
(17) |
|
|
— |
|
|
(17) |
|
|
(0.01) |
Adjusted Non-GAAP Results |
$ |
2,239 |
|
|
|
$ |
1,351 |
|
|
|
|
|
|
|
|
|
$ |
977 |
|
|
|
|
|
$ |
0.79 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 9 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Six Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross profit |
|
Selling, general and administrative expenses |
|
Operating income/(loss) |
|
Interest expense |
|
Other expense/(income) |
|
Income/(loss) before income taxes |
|
Provision for/(benefit from) income taxes |
|
Net income/(loss) |
|
Net income/(loss) attributable to noncontrolling interest |
|
Net income/(loss) attributable to common shareholders |
|
Diluted EPS |
|||||||||||
GAAP Results |
$ |
4,537 |
|
$ |
2,713 |
|
$ |
1,824 |
|
$ |
455 |
|
$ |
(8) |
|
$ |
1,377 |
|
$ |
473 |
|
$ |
904 |
|
$ |
1 |
|
$ |
903 |
|
$ |
0.74 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
2 |
|
|
2 |
|
|
— |
|
|
— |
|
|
1 |
|
|
(1) |
|
|
(1) |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
(33) |
|
|
— |
|
|
(33) |
|
|
— |
|
|
— |
|
|
(33) |
|
|
(7) |
|
|
(26) |
|
|
— |
|
|
(26) |
|
|
(0.02) |
Impairment losses |
|
— |
|
|
(854) |
|
|
854 |
|
|
— |
|
|
— |
|
|
854 |
|
|
— |
|
|
854 |
|
|
— |
|
|
854 |
|
|
0.70 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(79) |
|
|
79 |
|
|
25 |
|
|
54 |
|
|
— |
|
|
54 |
|
|
0.05 |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(4) |
|
|
4 |
|
|
— |
|
|
4 |
|
|
— |
|
|
4 |
|
|
— |
Adjusted Non-GAAP Results |
$ |
4,506 |
|
|
|
$ |
2,645 |
|
|
|
|
|
|
|
|
|
$ |
1,790 |
|
|
|
|
|
$ |
1.47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 10 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Six Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross profit |
|
Selling, general and administrative expenses |
|
Operating income/(loss) |
|
Interest expense |
|
Other expense/(income) |
|
Income/(loss) before income taxes |
|
Provision for/(benefit from) income taxes |
|
Net income/(loss) |
|
Net income/(loss) attributable to noncontrolling interest |
|
Net income/(loss) attributable to common shareholders |
|
Diluted EPS |
|||||||||||
GAAP Results |
$ |
4,374 |
|
$ |
1,755 |
|
$ |
2,619 |
|
$ |
455 |
|
$ |
(59) |
|
$ |
2,223 |
|
$ |
388 |
|
$ |
1,835 |
|
$ |
(1) |
|
$ |
1,836 |
|
$ |
1.49 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
— |
|
|
20 |
|
|
(20) |
|
|
— |
|
|
(2) |
|
|
(18) |
|
|
(3) |
|
|
(15) |
|
|
— |
|
|
(15) |
|
|
(0.01) |
Unrealized losses/(gains) on commodity hedges |
|
(5) |
|
|
— |
|
|
(5) |
|
|
— |
|
|
— |
|
|
(5) |
|
|
(1) |
|
|
(4) |
|
|
— |
|
|
(4) |
|
|
— |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
(2) |
|
|
2 |
|
|
— |
|
|
— |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(2) |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(18) |
|
|
18 |
|
|
— |
|
|
18 |
|
|
— |
|
|
18 |
|
|
0.01 |
Certain significant discrete income tax items |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
17 |
|
|
(17) |
|
|
— |
|
|
(17) |
|
|
(0.01) |
Adjusted Non-GAAP Results |
$ |
4,369 |
|
|
|
$ |
2,596 |
|
|
|
|
|
|
|
|
|
$ |
1,821 |
|
|
|
|
|
$ |
1.48 |
|
|
|
|
||||||||
|
|
|
|
|
Schedule 11 |
||||||
Adjusted Gross Profit Margin (dollars in millions) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Adjusted Gross Profit |
$ |
2,296 |
|
$ |
2,239 |
|
$ |
4,506 |
|
$ |
4,369 |
Net sales |
|
6,476 |
|
|
6,721 |
|
|
12,887 |
|
|
13,210 |
|
|
|
|
|
|
|
|
||||
Adjusted Gross Profit Margin |
|
35.5% |
|
|
33.3% |
|
|
35.0% |
|
|
33.1% |
|
|
|||||||
|
|
|
Schedule 12 |
|||||
(Unaudited) |
||||||||
|
For the Three Months Ended |
|
|
|||||
|
|
|
|
|
$ Change |
|||
Key drivers of change in Adjusted EPS: |
|
|
|
|
|
|||
Results of operations(a)(b) |
$ |
0.94 |
|
$ |
0.92 |
|
$ |
0.02 |
Interest expense |
|
(0.16) |
|
|
(0.16) |
|
|
— |
Other expense/(income) |
|
0.04 |
|
|
0.03 |
|
|
0.01 |
Effective tax rate |
|
(0.05) |
|
|
— |
|
|
(0.05) |
Effect of share repurchases |
|
0.01 |
|
|
— |
|
|
0.01 |
Adjusted EPS |
$ |
0.78 |
|
$ |
0.79 |
|
$ |
(0.01) |
(a) |
Includes non-cash amortization of definite-lived intangible assets, which accounted for a negative impact to Adjusted EPS from results of operations of |
(b) |
Includes divestiture-related license income, which accounted for a benefit to Adjusted EPS from results of operations of |
|
|
|||||||
|
|
|
Schedule 13 |
|||||
(Unaudited) |
||||||||
|
For the Six Months Ended |
|
|
|||||
|
|
|
|
|
$ Change |
|||
Key drivers of change in Adjusted EPS: |
|
|
|
|
|
|||
Results of operations(a)(b) |
$ |
1.76 |
|
$ |
1.73 |
|
$ |
0.03 |
Interest expense |
|
(0.30) |
|
|
(0.30) |
|
|
— |
Other expense/(income) |
|
0.05 |
|
|
0.05 |
|
|
— |
Effective tax rate |
|
(0.06) |
|
|
— |
|
|
(0.06) |
Effect of share repurchases |
|
0.02 |
|
|
— |
|
|
0.02 |
Adjusted EPS |
$ |
1.47 |
|
$ |
1.48 |
|
$ |
(0.01) |
(a) |
Includes non-cash amortization of definite-lived intangible assets, which accounted for a negative impact to Adjusted EPS from results of operations of |
(b) |
Includes divestiture-related license income, which accounted for a benefit to Adjusted EPS from results of operations of |
|
|
||||
|
Schedule 14 |
||||
Condensed Consolidated Balance Sheets (in millions, except per share data) (Unaudited) |
|||||
|
|
|
|
||
ASSETS |
|
|
|
||
Cash and cash equivalents |
$ |
900 |
|
$ |
1,400 |
Trade receivables, net |
|
2,160 |
|
|
2,112 |
Inventories |
|
3,573 |
|
|
3,614 |
Prepaid expenses |
|
273 |
|
|
234 |
Other current assets |
|
624 |
|
|
566 |
Assets held for sale |
|
— |
|
|
3 |
Total current assets |
|
7,530 |
|
|
7,929 |
Property, plant and equipment, net |
|
7,038 |
|
|
7,122 |
|
|
29,501 |
|
|
30,459 |
Intangible assets, net |
|
42,347 |
|
|
42,448 |
Other non-current assets |
|
2,381 |
|
|
2,381 |
TOTAL ASSETS |
$ |
88,797 |
|
$ |
90,339 |
LIABILITIES AND EQUITY |
|
|
|
||
Current portion of long-term debt |
|
669 |
|
|
638 |
Accounts payable |
|
4,448 |
|
|
4,627 |
Accrued marketing |
|
724 |
|
|
733 |
Interest payable |
|
260 |
|
|
258 |
Other current liabilities |
|
1,385 |
|
|
1,781 |
Total current liabilities |
|
7,486 |
|
|
8,037 |
Long-term debt |
|
19,265 |
|
|
19,394 |
Deferred income taxes |
|
10,173 |
|
|
10,201 |
Accrued postemployment costs |
|
137 |
|
|
143 |
Long-term deferred income |
|
1,400 |
|
|
1,424 |
Other non-current liabilities |
|
1,305 |
|
|
1,418 |
TOTAL LIABILITIES |
|
39,766 |
|
|
40,617 |
Redeemable noncontrolling interest |
|
10 |
|
|
34 |
Equity: |
|
|
|
||
Common stock, |
|
12 |
|
|
12 |
Additional paid-in capital |
|
52,086 |
|
|
52,037 |
Retained earnings/(deficit) |
|
1,297 |
|
|
1,367 |
Accumulated other comprehensive income/(losses) |
|
(2,738) |
|
|
(2,604) |
|
|
(1,762) |
|
|
(1,286) |
Total shareholders' equity |
|
48,895 |
|
|
49,526 |
Noncontrolling interest |
|
126 |
|
|
162 |
TOTAL EQUITY |
|
49,021 |
|
|
49,688 |
TOTAL LIABILITIES AND EQUITY |
$ |
88,797 |
|
$ |
90,339 |
|
|
||||
|
Schedule 15 |
||||
Condensed Consolidated Statements of Cash Flows (in millions) (Unaudited) |
|||||
|
For the Six Months Ended |
||||
|
|
|
|
||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
||
Net income/(loss) |
$ |
904 |
|
$ |
1,835 |
Adjustments to reconcile net income/(loss) to operating cash flows: |
|
|
|
||
Depreciation and amortization |
|
469 |
|
|
436 |
Amortization of postemployment benefit plans prior service costs/(credits) |
|
(4) |
|
|
(7) |
Divestiture-related license income |
|
(27) |
|
|
(27) |
Equity award compensation expense |
|
65 |
|
|
77 |
Deferred income tax provision/(benefit) |
|
(48) |
|
|
(34) |
Postemployment benefit plan contributions |
|
(9) |
|
|
(11) |
|
|
854 |
|
|
— |
Nonmonetary currency devaluation |
|
4 |
|
|
18 |
Loss/(gain) on sale of business |
|
79 |
|
|
2 |
Other items, net |
|
(56) |
|
|
(26) |
Changes in current assets and liabilities: |
|
|
|
||
Trade receivables |
|
(113) |
|
|
(114) |
Inventories |
|
(101) |
|
|
(232) |
Accounts payable |
|
(40) |
|
|
(156) |
Other current assets |
|
(114) |
|
|
(2) |
Other current liabilities |
|
(150) |
|
|
(175) |
Net cash provided by/(used for) operating activities |
|
1,713 |
|
|
1,584 |
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
||
Capital expenditures |
|
(543) |
|
|
(508) |
Proceeds from sale of business, net of cash disposed and working capital adjustments |
|
3 |
|
|
— |
Payments to acquire intangible assets |
|
(140) |
|
|
— |
Other investing activities, net |
|
48 |
|
|
33 |
Net cash provided by/(used for) investing activities |
|
(632) |
|
|
(475) |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
||
Repayments of long-term debt |
|
(606) |
|
|
(822) |
Proceeds from issuance of long-term debt |
|
593 |
|
|
657 |
Dividends paid |
|
(969) |
|
|
(982) |
Repurchases of common stock |
|
(537) |
|
|
(38) |
Other financing activities, net |
|
(46) |
|
|
(2) |
Net cash provided by/(used for) financing activities |
|
(1,565) |
|
|
(1,187) |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash |
|
(18) |
|
|
(14) |
Cash, cash equivalents, and restricted cash |
|
|
|
||
Net increase/(decrease) |
|
(502) |
|
|
(92) |
Balance at beginning of period |
|
1,404 |
|
|
1,041 |
Balance at end of period |
$ |
902 |
|
$ |
949 |
|
|
||||
|
Schedule 16 |
||||
Reconciliation of Net Cash Provided By/(Used For) Operating Activities to Free Cash Flow (in millions) (Unaudited) |
|||||
|
For the Six Months Ended |
||||
|
|
|
|
||
Net cash provided by/(used for) operating activities |
$ |
1,713 |
|
$ |
1,584 |
Capital expenditures |
|
(543) |
|
|
(508) |
Free Cash Flow |
$ |
1,170 |
|
$ |
1,076 |
|
|
|
|
||
Adjusted Net Income/(Loss) |
$ |
1,790 |
|
$ |
1,821 |
Free Cash Flow Conversion |
|
65% |
|
|
59% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731280115/en/
Alex.Abraham@kraftheinz.com
anne-marie.megela@kraftheinz.com
Source: